相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Improved Titer and Gene Transfer by Lentiviral Vectors Using Novel, Small β-Globin Locus Control Region Elements
Richard A. Morgan et al.
MOLECULAR THERAPY (2020)
Radioimmunotherapy in Combination with Reduced-Intensity Conditioning for Allogeneic Hematopoietic Cell Transplantation in Patients with Advanced Multiple Myeloma
Frederick Fasslrinner et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Improved health care utilization and costs in transplanted versus non-transplanted adults with sickle cell disease
Santosh L. Saraf et al.
PLOS ONE (2020)
Ruxolitinib: a potential treatment for corticosteroid refractory acute graft-versus-host disease
Sameem M. Abedin et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2020)
Finally, a Successful Randomized Trial for GVHD
Nelson Chao
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Risk score to predict event-free survival after hematopoietic cell transplant for sickle cell disease
Ruta Brazauskas et al.
BLOOD (2020)
Pain and opioid use after reversal of sickle cell disease following HLA-matched sibling haematopoietic stem cell transplant
Deepika S. Darbari et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
Prevalence and Profile of High-Impact Chronic Pain in the United States
Mark H. Pitcher et al.
JOURNAL OF PAIN (2019)
Nonmyeloablative Matched Sibling Donor Hematopoietic Cell Transplantation in Children and Adolescents with Sickle Cell Disease
Gregory M. T. Guilcher et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Association of Matched Sibling Donor Hematopoietic Stem Cell Transplantation With Transcranial Doppler Velocities in Children With Sickle Cell Anemia
Francoise Bernaudin et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Highly efficient therapeutic gene editing of human hematopoietic stem cells
Yuxuan Wu et al.
NATURE MEDICINE (2019)
Gene therapy targeting haematopoietic stem cells for inherited diseases: progress and challenges
Marina Cavazzana et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Risk factors and outcomes according to age at transplantation with an HLA-identical sibling for sickle cell disease
Barbara Cappelli et al.
HAEMATOLOGICA (2019)
Effect of increased dose of total body irradiation on graft failure associated with HLA-haploidentical transplantation in patients with severe haemoglobinopathies: a prospective clinical trial
Javier Bolanos-Meade et al.
LANCET HAEMATOLOGY (2019)
Antibody Conditioning Enables MHC-Mismatched Hematopoietic Stem Cell Transplants and Organ Graft Tolerance
Benson M. George et al.
CELL STEM CELL (2019)
CTLA4Ig-based reduced intensity conditioning and donor lymphocyte infusions for haploidentical transplantation in refractory aggressive B-cell lymphoma relapsing after an autograft: Early results from a pilot study
Sarita Rani Jaiswal et al.
EXPERIMENTAL HEMATOLOGY (2019)
Effect of donor type and conditioning regimen intensity on allogeneic transplantation outcomes in patients with sickle cell disease: a retrospective multicentre, cohort study
Mary Eapen et al.
LANCET HAEMATOLOGY (2019)
Systematic Review of l-glutamine for Prevention of Vaso-occlusive Pain Crisis in Patients with Sickle Cell Disease
Nicole E. Cieri-Hutcherson et al.
PHARMACOTHERAPY (2019)
Bone marrow transplantation for adolescents and young adults with sickle cell disease: Results of a prospective multicenter pilot study
Lakshmanan Krishnamurti et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
Autologous Stem-Cell-Based Gene Therapy for Inherited Disorders: State of the Art and Perspectives
Frank J. T. Staal et al.
FRONTIERS IN PEDIATRICS (2019)
Functional and Radiologic Assessment of the Brain after Reduced-Intensity Unrelated Donor Transplantation for Severe Sickle Cell Disease: Blood and Marrow Transplant Clinical Trials Network Study 0601
Allison A. King et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Haploidentical Bone Marrow Transplantation with Post-Transplantation Cyclophosphamide Plus Thiotepa Improves Donor Engraftment in Patients with Sickle Cell Anemia: Results of an International Learning Collaborative
Josu de la Fuente et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Decreased median survival of adults with sickle cell disease after adjusting for left truncation bias: a pooled analysis
Michael R. DeBaun et al.
BLOOD (2019)
Surgical Revascularization for Pediatric Patients with Sickle Cell Disease and Moyamoya Disease in the Prevention of Ischemic Strokes: A Single-Center Case Series and a Systematic Review
Pedro Aguilar-Salinas et al.
WORLD NEUROSURGERY (2019)
Biomarkers in acute graft-versus-host disease: new insights
Hrishikesh K. Srinagesh et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2019)
Invasive pneumococcal disease in children with sickle cell disease in the pneumococcal conjugate vaccine era
Olufunke O. Martin et al.
PEDIATRIC BLOOD & CANCER (2018)
Haploidentical Peripheral Blood Stem Cell Transplantation Demonstrates Stable Engraftment in Adults with Sickle Cell Disease
Santosh L. Saraf et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Ethical Challenges in Hematopoietic Cell Transplantation for Sickle Cell Disease
Robert Sheppard Nickel et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
HLA Haploidentical Stem Cell Transplant with Pretransplant Immunosuppression for Patients with Sickle Cell Disease
Anna B. Pawlowska et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Experiences and Decision Making in Hematopoietic Stem Cell Transplant in Sickle Cell Disease: Patients' and Caregivers' Perspectives
Kirshma Khemani et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Late Effects Screening Guidelines after Hematopoietic Cell Transplantation (HCT) for Hemoglobinopathy: Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT
Shalini Shenoy et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Gene therapy and gene editing strategies for hemoglobinopathies
Maria Rosa Lidonnici et al.
BLOOD CELLS MOLECULES AND DISEASES (2018)
Allogenic peripheral stem cell transplantation from HLA-matched related donors for adult sickle cell disease: remarkable outcomes from a single-center trial
H. Ozdogu et al.
BONE MARROW TRANSPLANTATION (2018)
The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation
Stefan O. Ciurea et al.
BONE MARROW TRANSPLANTATION (2018)
Genetic therapies for sickle cell disease
Erica B. Esrick et al.
SEMINARS IN HEMATOLOGY (2018)
Sickle cell disease
Gregory J. Kato et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
Gene Therapy for Sickle Cell Disease: A Lentiviral Vector Comparison Study
Fabrizia Urbinati et al.
HUMAN GENE THERAPY (2018)
HaploidenticalHSCT for hemoglobinopathies: improved outcomes with TCRαβ+/CD19+-depleted grafts
Javid Gaziev et al.
BLOOD ADVANCES (2018)
Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation
Eliane Gluckman et al.
BLOOD (2017)
Recipient and donor age impact the risk of developing chronic GvHD in children after allogeneic hematopoietic transplant
B. K. Watkins et al.
BONE MARROW TRANSPLANTATION (2017)
Clinical risks and healthcare utilization of hematopoietic cell transplantation for sickle cell disease in the USA using merged databases
Staci D. Arnold et al.
HAEMATOLOGICA (2017)
Gene Therapy in a Patient with Sickle Cell Disease
Jean-Antoine Ribeil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Double trouble: Complement-mediated thrombotic microangiopathy in patients with hemoglobinopathies after stem cell transplantation
Sonata Jodele
PEDIATRIC BLOOD & CANCER (2017)
Severe transplant-associated thrombotic microangiopathy in patients with hemoglobinopathies
Ghada A. Abusin et al.
PEDIATRIC BLOOD & CANCER (2017)
Clinical risks and healthcare utilization of hematopoietic cell transplantation for sickle cell disease in the USA using merged databases
Staci D. Arnold et al.
HAEMATOLOGICA (2017)
Immunohaematological complications in patients with sickle cell disease after haemopoietic progenitor cell transplantation: a prospective, single-centre, observational study
Elizabeth S. Allen et al.
LANCET HAEMATOLOGY (2017)
Proponent or collaborative: Physician perspectives and approaches to disease modifying therapies in sickle cell disease
Nitya Bakshi et al.
PLOS ONE (2017)
Relationship between Mixed Donor-Recipient Chimerism and Disease Recurrence after Hematopoietic Cell Transplantation for Sickle Cell Disease
Allistair Abraham et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
At least 20% donor myeloid chimerism is necessary to reverse the sickle phenotype after allogeneic HSCT
Courtney D. Fitzhugh et al.
BLOOD (2017)
Posterior Reversible Encephalopathy Syndrome after Hematopoietic Cell Transplantation in Children with Hemoglobinopathies
Javid Gaziev et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
Unrelated Umbilical Cord Blood Transplantation for Sickle Cell Disease Following Reduced-Intensity Conditioning: Results of a Phase I Trial
Allistair Abraham et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
Preclinical studies for a phase 1 clinical trial of autologous hematopoietic stem cell gene therapy for sickle cell disease
Fabrizia Urbinati et al.
CYTOTHERAPY (2017)
Alternative donor hematopoietic stem cell transplantation for sickle cell disease
Andrew L. Gilman et al.
BLOOD ADVANCES (2017)
Reduced toxicity, myeloablative HLA-haploidentical hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for sickle cell disease
Volker Wiebking et al.
ANNALS OF HEMATOLOGY (2017)
Haploidentical stem cell transplantation with CD3+-/CD19+-depleted peripheral stem cells for patients with advanced stage sickle cell disease and no alternative donor: results of a pilot study
J. Foell et al.
BONE MARROW TRANSPLANTATION (2017)
Cyclophosphamide improves engraftment in patients with SCD and severe organ damage who undergo haploidentical PBSCT
Courtney D. Fitzhugh et al.
BLOOD ADVANCES (2017)
Current Results and Future Research Priorities in Late Effects after Hematopoietic Stem Cell Transplantation for Children with Sickle Cell Disease and Thalassemia: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Stem Cell Transplantation
Shalini Shenoy et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
Kidney Disease among Patients with Sickle Cell Disease, Hemoglobin SS and SC
Paul Drawz et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Management of iron overload before, during, and after hematopoietic stem cell transplantation for thalassemia major
Emanuele Angelucci et al.
COOLEY'S ANEMIA (2016)
Nonmyeloablative Stem Cell Transplantation with Alemtuzumab/Low-Dose Irradiation to Cure and Improve the Quality of Life of Adults with Sickle Cell Disease
Santosh L. Saraf et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
A trial of unrelated donor marrow transplantation for children with severe sickle cell disease
Shalini Shenoy et al.
BLOOD (2016)
Phase I/II Trial of StemRegenin-1 Expanded Umbilical Cord Blood Hematopoietic Stem Cells Supports Testing as a Stand-Alone Graft
John E. Wagner et al.
CELL STEM CELL (2016)
Renal Failure in Sickle Cell Disease: Prevalence, Predictors of Disease, Mortality and Effect on Length of Hospital Stay
L. H. Yeruva et al.
HEMOGLOBIN (2016)
Lineage-specific BCL11A knockdown circumvents toxicities and reverses sickle phenotype
Christian Brendel et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
United States National Pain Strategy for Population Research: Concepts, Definitions, and Pilot Data
Michael Von Korff et al.
JOURNAL OF PAIN (2016)
Neurological PRESentations in Sickle Cell Patients Are Not Always Stroke: A Review of Posterior Reversible Encephalopathy Syndrome in Sickle Cell Disease
Ziad Solh et al.
PEDIATRIC BLOOD & CANCER (2016)
Improved Splenic Function After Hematopoietic Stem Cell Transplant for Sickle Cell Disease
Robert Sheppard Nickel et al.
PEDIATRIC BLOOD & CANCER (2016)
Successful matched sibling donor marrow transplantation following reduced intensity conditioning in children with hemoglobinopathies
Allison A. King et al.
AMERICAN JOURNAL OF HEMATOLOGY (2015)
Using Fludarabine to Reduce Exposure to Alkylating Agents in Children with Sickle Cell Disease Receiving Busulfan, Cyclophosphamide, and Antithymocyte Globulin Transplant Conditioning: Results of a Dose De-Escalation Trial
John T. Horan et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
ABO Mismatch Is Associated with Increased Nonrelapse Mortality after Allogeneic Hematopoietic Cell Transplantation
Aaron C. Logan et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Health-Related Quality of Life after Allogeneic Hematopoietic Stem Cell Transplantation for Sickle Cell Disease
Monica Bhatia et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
How I treat and manage strokes in sickle cell disease
Adetola A. Kassim et al.
BLOOD (2015)
Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in children with sickle cell disease
Luisa Strocchio et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Allogeneic donor availability for hematopoietic stem cell transplantation in children with sickle cell disease
David Justus et al.
PEDIATRIC BLOOD & CANCER (2015)
Current attitudes of parents and patients toward hematopoietic stem cell transplantation for sickle cell anemia
Emily Riehm Meier et al.
PEDIATRIC BLOOD & CANCER (2015)
Is ABO mismatch another risk factor for allogeneic hematopoietic stem cell transplantation in pediatric thalassemic patients?
Didem Atay et al.
PEDIATRIC TRANSPLANTATION (2015)
Conditioning regimens for hematopoietic cell transplantation: one size does not fit all
Boglarka Gyurkocza et al.
BLOOD (2014)
The ethics of a proposed study of hematopoietic stem cell transplant for children with less severe sickle cell disease
Robert S. Nickel et al.
BLOOD (2014)
Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel
Emanuele Angelucci et al.
HAEMATOLOGICA (2014)
Nonmyeloablative HLA-Matched Sibling Allogeneic Hematopoietic Stem Cell Transplantation for Severe Sickle Cell Phenotype
Matthew M. Hsieh et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
HLA Match Likelihoods for Hematopoietic Stem-Cell Grafts in the US Registry
Loren Gragert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Risk Factors for Death in 632 Patients with Sickle Cell Disease in the United States and United Kingdom
Mark T. Gladwin et al.
PLOS ONE (2014)
Clinical Guide to ASO-Incompatible Allogeneic Stem Cell Transplantation
Garrett S. Booth et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Efficacy and Long-Term Outcome of Treatment for Pure Red Cell Aplasia after Allogeneic Stem Cell Transplantation from Major ABO-Incompatible Donors
Makoto Hirokawa et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Long-Term Outcome and Evaluation of Organ Function in Pediatric Patients Undergoing Haploidentical and Matched Related Hematopoietic Cell Transplantation for Sickle Cell Disease
Mari H. Dallas et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Outcome of patients with hemoglobinopathies given either cord blood or bone marrow transplantation from an HLA-identical sibling
Franco Locatelli et al.
BLOOD (2013)
Graft failure in the modern era of allogeneic hematopoietic SCT
R. Olsson et al.
BONE MARROW TRANSPLANTATION (2013)
Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates
Frederic B. Piel et al.
LANCET (2013)
Global Burden of Sickle Cell Anaemia in Children under Five, 2010-2050: Modelling Based on Demographics, Excess Mortality, and Interventions
Frederic B. Piel et al.
PLOS MEDICINE (2013)
Unrelated Donor Cord Blood Transplantation for Children with Severe Sickle Cell Disease: Results of One Cohort from the Phase II Study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN)
Naynesh R. Kamani et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
Evaluation of HLA matching in unrelated hematopoietic stem cell transplantation for nonmalignant disorders
John Horan et al.
BLOOD (2012)
HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease
Javier Bolanos-Meade et al.
BLOOD (2012)
Health-related quality of life in sickle cell disease: Past, present, and future
Julie A. Panepinto et al.
PEDIATRIC BLOOD & CANCER (2012)
Umbilical Cord Blood Transplantation for Children with Thalassemia and Sickle Cell Disease
Annalisa Ruggeri et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Biomarkers of splenic function in infants with sickle cell anemia: baseline data from the BABY HUG Trial
Zora R. Rogers et al.
BLOOD (2011)
Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria
Mary E. D. Flowers et al.
BLOOD (2011)
Milestones in umbilical cord blood transplantation
Eliane Gluckman et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Population Estimates of Sickle Cell Disease in the US
Kathryn L. Hassell
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2010)
Pulmonary, Gonadal, and Central Nervous System Status after Bone Marrow Transplantation for Sickle Cell Disease
Mark C. Walters et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
Desferrioxamine therapy accelerates clearance of iron deposits after bone marrow transplantation for thalassaemia
C. Giardini et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Renal Function in Infants with Sickle Cell Anemia: Baseline Data from the BABY HUG Trial
Russell E. Ware et al.
JOURNAL OF PEDIATRICS (2010)
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
Marcie Tomblyn et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Defining the Intensity of Conditioning Regimens: Working Definitions
Andrea Bacigalupo et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Silent infarcts in young children with sickle cell disease
Janet L. Kwiatkowski et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Daily assessment of pain in adults with sickle cell disease
Wally R. Smith et al.
ANNALS OF INTERNAL MEDICINE (2008)
Stable Long-Term Donor Engraftment following Reduced-Intensity Hematopoietic Cell Transplantation for Sickle Cell Disease
Lakshmanan Krishnamurti et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Mixed haematopoietic chimerism for sickle cell disease prevents intravascular haemolysis
Catherine J. Wu et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease
Francoise Bernaudin et al.
BLOOD (2007)
Hematopoietic stem cell transplantation for multiply transfused patients with sickle cell disease and thalassemia after low-dose total body irradiation, fludarabine, and rabbit anti-thymocyte globulin
JT Horan et al.
BONE MARROW TRANSPLANTATION (2005)
Pulmonary hypertension as a risk factor for death in patients with sickle cell disease
MT Gladwin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and β-thalassemia
R Iannone et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2003)
Poor school and cognitive functioning with silent cerebral infarcts and sickle cell disease
J Schatz et al.
NEUROLOGY (2001)
Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia
MC Walters et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2001)
分享论文
